title: Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma.
authors.forename: F
authors.initials: F
authors.lastname: Rosenow
authors.forename: P S
authors.initials: PS
authors.lastname: Reif
authors.forename: A
authors.initials: A
authors.lastname: Haag
authors.forename: K
authors.initials: K
authors.lastname: Schmidt
authors.forename: H
authors.initials: H
authors.lastname: Strik
mesh_terms: D000927:Anticonvulsants / Q000494:pharmacology* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000819:agonists / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000401:mortality* / Q000473:pathology; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards; D015897:Comorbidity; D003627:Data Interpretation, Statistical; D018450:Disease Progression; D004798:Enzymes / Q000187:drug effects / Q000378:metabolism; D004827:Epilepsy / Q000188:drug therapy / Q000453:epidemiology* / Q000503:physiopathology; D005909:Glioblastoma / Q000188:drug therapy* / Q000401:mortality* / Q000473:pathology; D006801:Humans; D015994:Incidence; D017063:Outcome Assessment, Health Care / Q000379:methods / Q000592:standards; D012720:Severity of Illness Index; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D000970:Antineoplastic Agents; D004798:Enzymes